Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer

The American Journal of Medicine - Tập 113 Số 9 - Trang 71-88 - 2002
Penny M. Kris‐Etherton1, Kari D. Hecker2, A Bonanome3, Stacie M. Coval2, Amy E. Binkoski2, Kirsten F. Hilpert2, Amy E. Griel2, Terry D. Etherton2
1Graduate Program in Nutrition, Pennsylvania State University, University Park, Pennsylvania, USA.
2Graduate Program in Nutrition, Pennsylvania State University, University Park, Pennsylvania, USA (PMK, KDH, SMC, AEB, KFH, AEG, TDE)
3Department of Internal Medicine, University of Padua, Padua, Italy (AB)

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hu, 2002, Dietary pattern analysis, Curr Opin Lipidol, 13, 3, 10.1097/00041433-200202000-00002

2002

Verschuren, 1995, Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty five-year follow-up of the Seven Countries Study, JAMA, 274, 131, 10.1001/jama.1995.03530020049031

Kitts, 1994, Bioactive substances in food, Can J Physiol Pharmacol, 72, 423, 10.1139/y94-062

Dapkevicius A. Isolation, Identification and Evaluation of Natural Antioxidants from Aromatic Herbs Cultivated in Lithuania. PhD Thesis. Wageningen, Netherlands: Wageningen University, 2002

Bazzano, 2002, Fruit and vegetable intake and risk of cardiovascular disease in US adults, Am J Clin Nutr, 76, 93, 10.1093/ajcn/76.1.93

Gillman, 1995, Protective effect of fruits and vegetables on development of stroke in men, JAMA, 273, 1113, 10.1001/jama.1995.03520380049034

Joshipura, 2001, The effect of fruit and vegetable intake on risk for coronary heart disease, Ann Intern Med, 134, 1106, 10.7326/0003-4819-134-12-200106190-00010

Liu, 2001, Intake of vegetables rich in carotenoids and risk of coronary heart disease in men, Int J Epidemiol, 30, 130, 10.1093/ije/30.1.130

Liu, 2000, Fruit and vegetable intake and risk of cardiovascular disease, Am J Clin Nutr, 72, 922, 10.1093/ajcn/72.4.922

Sasazuki, 2001, Case-control study of nonfatal myocardial infarction in relation to selected foods in Japanese men and women, Jpn Circ J, 65, 200, 10.1253/jcj.65.200

Zhao, 2001, Implications from and for food cultures for cardiovascular disease, Asia Pacific J Clin Nutr, 10, 146, 10.1046/j.1440-6047.2001.00224.x

Menotti, 1999, Food intake patterns and 25-year mortality from coronary heart disease, Eur J Epidemiol, 15, 507, 10.1023/A:1007529206050

Rosengren, 1999, Coronary risk factors, diet and vitamins as possible explanatory factors of the Swedish north-south gradient in coronary disease, J Intern Med, 246, 577, 10.1046/j.1365-2796.1999.00616.x

Gandini, 2000, Meta-analysis of studies on breast cancer risk and diet, Eur J Cancer, 36, 636, 10.1016/S0959-8049(00)00022-8

Smith-Warner, 2001, Intake of fruits and vegetables and risk of breast cancer, JAMA, 14, 769, 10.1001/jama.285.6.769

Kolonel, 2000, Vegetables, fruits, legumes and prostate cancer, Cancer Epidemiol Biomark Prev, 9, 795

Feskanich, 2000, Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women, J Natl Cancer Inst, 92, 1812, 10.1093/jnci/92.22.1812

Michels, 2000, Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers, J Natl Cancer Inst, 92, 1740, 10.1093/jnci/92.21.1740

Anderson, 2000, Whole grain foods and heart disease risk, J Am Coll Nutr, 19, 291S, 10.1080/07315724.2000.10718963

Pietinen, 1996, Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, Circulation, 94, 2720, 10.1161/01.CIR.94.11.2720

Fraser, 1992, A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study, Arch Intern Med, 152, 1416, 10.1001/archinte.1992.00400190054010

Liu, 1999, Whole-grain consumption and risk of coronary heart disease, Am J Clin Nutr, 70, 412, 10.1093/ajcn/70.3.412

Liu, 2000, Whole grain consumption and risk of ischemic stroke in women, JAMA, 284, 1534, 10.1001/jama.284.12.1534

McKeown, 2002, Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study, Am J Clin Nutr, 76, 390, 10.1093/ajcn/76.2.390

Jacobs, 2000, Fiber from whole grains, but not refined grains, is inversely associated with all-cause mortality in older women, J Am Coll Nutr, 19, 326S, 10.1080/07315724.2000.10718968

Jacobs, 1998, Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women, Am J Clin Nutr, 68, 248, 10.1093/ajcn/68.2.248

Jacobs, 1999, Is whole grain intake associated with reduced total and cause-specific death rates in older women? The Iowa Women’s Health Study, Am J Public Health, 89, 322, 10.2105/AJPH.89.3.322

Bazzano, 2001, Legume consumption and risk of coronary heart disease in US men and women, Arch Intern Med, 161, 2573, 10.1001/archinte.161.21.2573

Rotondo, 2000, Protection from cardiovascular disease by wine and its derived products, World Rev Nutr Diet, 87, 90, 10.1159/000059720

Artalejo, 1997, Socioeconomic level, sedentary lifestyle, and wine consumption as possible explanations for geographic distribution of cerebrovascular disease mortality in Spain, Stroke, 28, 922, 10.1161/01.STR.28.5.922

Stampfer, 1988, A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women, N Engl J Med, 319, 267, 10.1056/NEJM198808043190503

Gronbaek, 2000, Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer, Ann Intern Med, 133, 411, 10.7326/0003-4819-133-6-200009190-00008

Klatsky, 1997, Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization, Am J Cardiol, 80, 416, 10.1016/S0002-9149(97)00388-3

Criqui, 1994, Does diet or alcohol explain the French paradox?, Lancet, 344, 1719, 10.1016/S0140-6736(94)92883-5

Truelsen, 1998, Intake of beer, wine, and spirits and risk of stroke, Stroke, 29, 2467, 10.1161/01.STR.29.12.2467

Sacco, 1999, The protective effect of moderate alcohol consumption on ischemic stroke, JAMA, 281, 53, 10.1001/jama.281.1.53

Bravo, 1998, Polyphenols, Nutr Rev, 56, 317, 10.1111/j.1753-4887.1998.tb01670.x

Sampson, 2002, Flavonol and flavone intakes in US health professionals, J Am Diet Assoc, 102, 1414, 10.1016/S0002-8223(02)90314-7

Peterson, 1998, Flavonoids, Nutr Res, 18, 1995, 10.1016/S0271-5317(98)00169-9

Hertog, 1993, Dietary antioxidant flavonoids and risk of coronary heart disease, Lancet, 342, 1007, 10.1016/0140-6736(93)92876-U

Hertog, 1995, Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study, Arch Intern Med, 155, 381, 10.1001/archinte.1995.00430040053006

Knekt, 1996, Flavonoid intake and coronary mortality in Finland, BMJ, 312, 478, 10.1136/bmj.312.7029.478

Yochum, 1999, Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women, Am J Epidemiol, 149, 943, 10.1093/oxfordjournals.aje.a009738

Rimm, 1996, Relation between intake of flavonoids and risk for coronary heart disease in male health professionals, Ann Intern Med, 125, 384, 10.7326/0003-4819-125-5-199609010-00005

Frankel, 1993, Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine, Lancet, 341, 454, 10.1016/0140-6736(93)90206-V

Dwyer, 1994, Tofu and soy drinks contain phytoestrogens, J Am Diet Assoc, 94, 739, 10.1016/0002-8223(94)91939-9

Janssen, 1998, Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers, Am J Clin Nutr, 67, 255, 10.1093/ajcn/67.2.255

German, 2000, The health benefits of wine, Annu Rev Nutr, 20, 561, 10.1146/annurev.nutr.20.1.561

Kerry, 1997, Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro, Atherosclerosis, 135, 93, 10.1016/S0021-9150(97)00156-1

Duthie, 1998, The effect of whisky and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers, Eur J Clin Nutr, 52, 733, 10.1038/sj.ejcn.1600635

Singleton, 1988, Wine phenols, vol 6, 173

Nardini, 1995, Inhibition of human low-density lipoprotein oxidation by caffeic and other hydroxycinnamic acid derivatives, Free Radic Biol Med, 19, 541, 10.1016/0891-5849(95)00052-Y

Abu-Amsha, 1996, Phenolic content of various beverages determines the extent of inhibition of human serum and low density lipoprotein oxidation in vitro, Clin Sci, 91, 449, 10.1042/cs0910449

Frankel, 1993, Inhibition of human LDL oxidation by resveratrol, Lancet, 341, 1103, 10.1016/0140-6736(93)92472-6

DeWhalley, 1990, Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages, Biochem Pharm, 39, 1743, 10.1016/0006-2952(90)90120-A

Manach, 1995, Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin, J Nutr, 125, 1911, 10.1093/jn/125.7.1911

Vinson, 1995, Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro model for heart disease, J Agric Food Chem, 45, 2800, 10.1021/jf00059a005

Mangiapane, 1992, The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid, Biochem Pharm, 43, 445, 10.1016/0006-2952(92)90562-W

Salah, 1995, Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants, Arch Biochem Biophys, 322, 339, 10.1006/abbi.1995.1473

Lanninghamfoster, 1995, Grape extract inhibits lipid peroxidation of human low density lipoprotein, Biol Pharm Bull, 18, 1347, 10.1248/bpb.18.1347

Rotondo, 2000, Protection from cardiovascular disease by wine and its derived products. Epidemiological evidence and biological mechanisms, World Rev Nutr Diet, 87, 90, 10.1159/000059720

Wollin, 2001, Alcohol, red wine and cardiovascular disease, J Nutr, 131, 1401, 10.1093/jn/131.5.1401

Freedman, 2001, Select flavonoid and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release, Circulation, 103, 2792, 10.1161/01.CIR.103.23.2792

Kondo, 1996, Inhibition of LDL oxidation by cocoa, Lancet, 348, 1514, 10.1016/S0140-6736(05)65927-2

Sanbongi, 1997, Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro, Cell Immunol, 177, 129, 10.1006/cimm.1997.1109

Rein, 2000, Cocoa and wine polyphenols modulate platelet activation and function, J Nutr, 130, 2120S, 10.1093/jn/130.8.2120S

Waterhouse, 1996, Antioxidants in chocolate, Lancet, 348, 834, 10.1016/S0140-6736(05)65262-2

Wan, 2001, Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin levels in humans, Am J Clin Nutr, 74, 596, 10.1093/ajcn/74.5.596

Pace-Asciak, 1995, The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis, Clin Chim Acta, 235, 207, 10.1016/0009-8981(95)06045-1

Rein, 2000, Cocoa inhibits platelet activation and function, Am J Clin Nutr, 72, 30, 10.1093/ajcn/72.1.30

Schramm, 2001, Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells, Am J Clin Nutr, 73, 36, 10.1093/ajcn/73.1.36

DeVries, 1997, Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets, Cancer Lett, 114, 141, 10.1016/S0304-3835(97)04645-4

Chung, 1993, Antiplatelet effects and vasorelaxing action of some constituents of formosan plants, J Nat Prod, 56, 929, 10.1021/np50096a018

Tzeng, 1991, Inhibition of platelet aggregation by some flavonoids, Throm Res, 64, 91, 10.1016/0049-3848(91)90208-E

Conquer, 1998, Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects, J Nutr, 128, 593, 10.1093/jn/128.3.593

McAnlis, 1999, Absorption and antioxidant effects of quercetin from onions, in man, Eur J Clin Nutr, 53, 92, 10.1038/sj.ejcn.1600682

Hollman, 1996, Role of dietary flavonoids in protection against cancer and coronary heart disease, Biochem Soc Trans, 24, 785, 10.1042/bst0240785

Rice-Evans, 1996, Antioxidant activities of flavonoids as bioactive components of food, Biochem Soc Trans, 24, 790, 10.1042/bst0240790

Tham, 1998, Potential health benefits of dietary phytoestrogens, J Clin Endocrinol Metab, 83, 2223

Yang, 2001, Inhibition of carcinogenesis by dietary polyphenolic compounds, Annu Rev Nutr, 21, 381, 10.1146/annurev.nutr.21.1.381

Hasler, 1998, Functional foods, Food Tech, 52, 63

Verma, 1988, Inhibition of 7,12 dimethylbenz(a)anthracene and N-nitrosomethylurea induced rat mammary cancer by dietary flavonol quercetin, Cancer Res, 48, 5754

Deschner, 1991, Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia, Carcinogenesis, 7, 1193, 10.1093/carcin/12.7.1193

Bonanome, 1992, Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification, Arterioscler Thromb, 12, 529, 10.1161/01.ATV.12.4.529

Covas, 2000, Virgin olive oil phenolic compounds, Int J Clin Pharmacol Res, 20, 49

Hargrove, 2001, Low fat and high monounsaturated fat diets decrease human low density lipoprotein oxidative susceptibility in vitro, J Nutr, 131, 1758, 10.1093/jn/131.6.1758

Visioli, 2000, Olive phenol hydroxytyrosol prevents passive smoking induced oxidative stress, Circulation, 102, 2169, 10.1161/01.CIR.102.18.2169

Oubina, 2001, Eicosanoid production, thrombogenic ratio, and serum and LDL peroxides in normo- and hypercholesterolaemic postmenopausal women consuming two oleic acid enriched diets with different content of minor components, Br J Nutr, 85, 41, 10.1079/BJN2000230

Lee, 2000, Consumption of tomato products with olive oil but not sunflower oil increases the antioxidant activity of plasma, Free Radic Biol Med, 29, 1051, 10.1016/S0891-5849(00)00440-8

Bonanome, 2000, Evidence of postprandial absorption of olive oil phenols in humans, Nutr Metab Cardiovasc Dis, 10, 111

Vissers, 2001, Effect of phenol-rich extra virgin olive oil on markers of oxidation in healthy volunteers, Eur J Clin Nutr, 55, 334, 10.1038/sj.ejcn.1601161

Gutfinger, 1981, Polyphenols in olive oils, J Am Oil Chem Soc, 58, 966, 10.1007/BF02659771

Montedoro, 1992, Simple and hydrolyzable phenolic compounds in virgin olive oil, J Agric Food Chem, 40, 1571, 10.1021/jf00021a019

Wiseman, 1996, Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits, Atherosclerosis, 120, 15, 10.1016/0021-9150(95)05656-4

Scaccini, 1992, Effect of dietary oils on lipid peroxidation and on antioxidant parameters of rat plasma and lipoprotein fractions, J Lipid Res, 33, 627, 10.1016/S0022-2275(20)41427-0

Kurzer, 1997, Dietary phytoestrogens, Annu Rev Nutr, 17, 353, 10.1146/annurev.nutr.17.1.353

Setchell, 1999, Dietary isoflavones, J Nutr, 129, 758S, 10.1093/jn/129.3.758S

Bingham, 1998, Phyto-oestrogens, Br J Nutr, 79, 393, 10.1079/BJN19980068

Anderson, 1995, Meta-analysis of the effects of soy protein intake on serum lipids, N Engl J Med, 333, 276, 10.1056/NEJM199508033330502

Anthony, 1996, Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system in prepubertal monkeys, J Nutr, 126, 43, 10.1093/jn/126.1.43

Hodgson, 1998, Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations, J Nutr, 128, 728, 10.1093/jn/128.4.728

Gooderham, 1996, A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentration, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men, J Nutr, 126, 2000

Simons, 2000, Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women, Am J Cardiol, 85, 1297, 10.1016/S0002-9149(00)00759-1

Crouse, 1999, A randomized trial comparing the effects of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins, Arch Intern Med, 159, 2070, 10.1001/archinte.159.17.2070

Xu, 1995, Bioavailability of soybean isoflavones depends upon gut microflora in women, J Nutr, 125, 2307, 10.1093/jn/125.9.2307

Anthony, 1997, Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys, Arterioscler Thromb Vasc Biol, 17, 2524, 10.1161/01.ATV.17.11.2524

Honoré, 1997, Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques, Fertil Steril, 67, 148, 10.1016/S0015-0282(97)81872-9

Tikkanen, 1998, Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance, Proc Natl Acad Sci U S A, 95, 3106, 10.1073/pnas.95.6.3106

Sargeant, 1993, The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets, FEBS Lett, 315, 242, 10.1016/0014-5793(93)81172-V

Nestel, 1991, Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women, Arterioscler Thromb Vasc Biol, 17, 3392, 10.1161/01.ATV.17.12.3392

Jenkins, 2002, Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women, Am J Clin Nutr, 76, 365, 10.1093/ajcn/76.2.365

Teede, 2001, Dietary soy has both beneficial and potentially adverse cardiovascular effects, J Clin Endocrinol Metab, 86, 3053

Jenkins, 1999, Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity, Am J Clin Nutr, 69, 395, 10.1093/ajcn/69.3.395

Xue, 1992, Antioxidant activity of two dibenzocyclooctene lignans on the aged and ischemic brain in rats, Free Radic Biol Med, 12, 127, 10.1016/0891-5849(92)90006-3

McMichael-Phillips, 1998, Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast, Am J Clin Nutr, 68, 1431S, 10.1093/ajcn/68.6.1431S

Petrakis, 1996, Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women, Cancer Epidemiol Biomarkers Prev, 5, 785

Allred, 2001, Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner, Cancer Res, 61, 5045

Jang, 1997, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science, 275, 218, 10.1126/science.275.5297.218

Pendurthi, 1999, Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells, Arterioscler Thromb Vasc Biol, 19, 419, 10.1161/01.ATV.19.2.419

Hung, 2000, Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes, Cardiovasc Res, 47, 549, 10.1016/S0008-6363(00)00102-4

Lu, 1999, Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells, J Cell Physiol, 179, 297, 10.1002/(SICI)1097-4652(199906)179:3<297::AID-JCP7>3.0.CO;2-P

Bertelli, 1998, Plasma and tissue resveratrol concentrations and pharmacological activity, Drugs Exp Clin Res, 24, 133

Nguyen, 1999, Lycopene, Food Tech, 53, 38

Clinton, 1998, Lycopene, Nutr Rev, 56, 35, 10.1111/j.1753-4887.1998.tb01691.x

Weisburger, 1998, Evaluation of the evidence on the role of tomato products in disease prevention, Proc Soc Exp Biol Med, 218, 140, 10.3181/00379727-218-44281

Kohlmeier, 1997, Lycopene and myocardial infarction risk in the EURAMIC study, Am J Epidemiol, 146, 618, 10.1093/oxfordjournals.aje.a009327

Street, 1994, Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction?, Circulation, 90, 1154, 10.1161/01.CIR.90.3.1154

Fuhrman, 1997, Hypercholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages, Biochem Biophys Res Commun, 233, 658, 10.1006/bbrc.1997.6520

Arab, 2000, Lycopene and cardiovascular disease, Am J Clin Nutr, 71, 1691S, 10.1093/ajcn/71.6.1691S

Dugas, 1998, Impact of LDL carotenoids and alpha-tocopherol content on LDL oxidation by endothelial cells in culture, J Lipid Res, 39, 999, 10.1016/S0022-2275(20)33867-0

Giovannucci, 1999, Tomatoes, tomato-based products, lycopene, and cancer, J Natl Cancer Inst, 91, 317, 10.1093/jnci/91.4.317

Krinsky, 1998, Overview of lycopene, carotenoids, and disease prevention, Proc Soc Exp Biol Med, 218, 95, 10.3181/00379727-218-44273

La Vecchia, 1998, Mediterranean epidemiological evidence on tomatoes and the prevention of digestive-tract cancers, Proc Soc Exp Biol Med, 218, 125, 10.3181/00379727-218-44276

Rao, 1998, Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer, Nutr Cancer, 31, 199, 10.1080/01635589809514703

Agarwal, 2000, Tomato lycopene and its role in human health and chronic diseases, CMAJ, 163, 739

Gore, 1994, Cardiovascular disease, JAMA, 271, 1660, 10.1001/jama.1994.03510450032017

Warshafsky, 1993, Effects of garlic on total serum cholesterol, Ann Intern Med, 119, 599, 10.7326/0003-4819-119-7_Part_1-199310010-00009

Matsuura, 2001, Saponins in garlic as modifiers of the risk of cardiovascular disease, J Nutr, 131, 1000S, 10.1093/jn/131.3.1000S

Isaacsohn, 1998, Garlic powder and plasma lipids and lipoproteins, Arch Intern Med, 158, 1189, 10.1001/archinte.158.11.1189

Pentz, 1996, Garlic preparations

Steiner, 1996, A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids, Am J Clin Nutr, 64, 866, 10.1093/ajcn/64.6.866

Borek, 2001, Antioxidant health effects of aged garlic extract, J Nutr, 131, 1010S, 10.1093/jn/131.3.1010S

Amagase H. Intake of garlic and its components [abstract]. Nutritional and Health Benefits of Garlic as a Supplement Conference; November 15–17, 1998; Newport Beach, California

Jain, 1993, Can garlic reduce levels of serum lipids? A controlled clinical study, Am J Med, 94, 632, 10.1016/0002-9343(93)90216-C

Silagy, 1994, A meta-analysis of the effect of garlic on blood pressure, J Hypertens, 12, 463, 10.1097/00004872-199404000-00017

Agarwal, 1996, Therapeutic actions of garlic constituents, Med Res Rev, 16, 111, 10.1002/(SICI)1098-1128(199601)16:1<111::AID-MED4>3.0.CO;2-5

Sumiyoshi, 1989, Garlic (Allium sativum), Asia Pacific Journal of Pharmacology, 4, 133

Heber, 1997, The stinking rose, Am J Clin Nutr, 66, 425, 10.1093/ajcn/66.2.425

Fukushima, 1997, Cancer prevention by organosulfur compounds from garlic and onion, J Cell Biochem Suppl, 27, 100, 10.1002/(SICI)1097-4644(1997)27+<100::AID-JCB16>3.0.CO;2-R

Hirsch, 2000, Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation, Nutr Cancer, 38, 245, 10.1207/S15327914NC382_14

Imai, 1994, Antioxidant and radical scavenging effects of aged garlic extract and its constituents, Planta Med, 60, 417, 10.1055/s-2006-959522

Milner, 2001, Mechanism by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis, Adv Exp Med Biol, 492, 69, 10.1007/978-1-4615-1283-7_7

Ling, 1995, Dietary phytosterols, Life Sci, 57, 195, 10.1016/0024-3205(95)00263-6

Vahouny, 1981, Plant and marine sterols and cholesterol metabolism, 31

Heinemann, 1986, Effect of low-dose sitostanol on serum cholesterol in patients with hypercholesterolemia, Atherosclerosis, 61, 219, 10.1016/0021-9150(86)90141-3

Gylling, 1994, Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment, Diabetologia, 37, 773, 10.1007/BF00404334

Vanhanen, 1994, Serum levels, absorption efficiency, faecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolaemic subjects, Clin Sci, 87, 61, 10.1042/cs0870061

Gylling, 1995, Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia, J Lipid Res, 36, 1807, 10.1016/S0022-2275(20)41499-3

Miettinen, 1995, Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population, N Engl J Med, 333, 1308, 10.1056/NEJM199511163332002

Niinikoski, 1997, Cholesterol-lowering effect and sensory properties of sitostanol ester margarine in normocholesterolemic adults, Scand J Nutr, 41, 9

Gylling, 1997, Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Women and dietary sitostanol, Circulation, 96, 4226, 10.1161/01.CIR.96.12.4226

Maki, 2001, Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet, Am J Clin Nutr, 74, 33, 10.1093/ajcn/74.1.33

Jones, 1998, Comparable efficacy of hydrogenated versus nonhydrogenated plant sterol esters on circulating cholesterol levels in humans, Nutr Rev, 56, 245, 10.1111/j.1753-4887.1998.tb01756.x

Lichtenstein, 1994, Hypercholesterolemic effect of dietary cholesterol in diets enriched in polyunsaturated and saturated fat. Dietary cholesterol, fat saturation, and plasma lipids, Arterioscler Thromb, 14, 168, 10.1161/01.ATV.14.1.168

Tomeo, 1995, Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis, Lipids, 30, 1179, 10.1007/BF02536621

Todd, 1999, Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality, Am J Epidemiol, 150, 1073, 10.1093/oxfordjournals.aje.a009931

Wolk, 1999, Long-term intake of dietary fiber and decreased risk of coronary heart disease among women, JAMA, 281, 1998, 10.1001/jama.281.21.1998

Anderson, 2000, Whole grain foods and heart disease risk, J Am Coll Nutr, 19, 291S, 10.1080/07315724.2000.10718963

Ripsin, 1992, Oat products and lipid lowering, JAMA, 267, 3317, 10.1001/jama.1992.03480240079039

Brown, 1999, Cholesterol-lowering effects of dietary fiber, Am J Clin Nutr, 69, 30, 10.1093/ajcn/69.1.30

Anderson, 2000, Dietary fiber prevents carbohydrate-induced hypertriglyceridemia, Curr Atheroscler Rep, 2, 536, 10.1007/s11883-000-0055-7

Chandalia, 2000, Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus, N Engl J Med, 342, 1392, 10.1056/NEJM200005113421903

Weisburger, 1999, Tea and health, Proc Soc Exp Biol Med, 220, 271, 10.3181/00379727-220-44378

Hollman, 1999, Tea flavonols in cardiovascular disease and cancer epidemiology, Proc Soc Exp Biol Med, 220, 198, 10.3181/00379727-220-44365

Riemersma, 2001, Tea flavonoids and cardiovascular health, QJM, 94, 277, 10.1093/qjmed/94.5.277

Sasazuki, 2000, Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women, Ann Epidemiol, 10, 401, 10.1016/S1047-2797(00)00066-1

Yang, 2000, Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation, Atherosclerosis, 148, 67, 10.1016/S0021-9150(99)00239-7

Miura, 2000, Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins, J Nutr Biochem, 11, 216, 10.1016/S0955-2863(00)00068-1

van het Hof, 1999, Plasma and lipoprotein levels of tea catechins following repeated tea consumption, Proc Soc Exp Biol Med, 220, 203, 10.3181/00379727-220-44366

Tijburg, 1997, Tea flavonoids and cardiovascular diseases, Crit Rev Food Sci Nutr, 37, 771, 10.1080/10408399709527802

Fujiki, 1998, Cancer inhibition by green tea, Mutat Res, 402, 307, 10.1016/S0027-5107(97)00310-2

Zheng, 1996, Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women, Am J Epidemiol, 144, 175, 10.1093/oxfordjournals.aje.a008905

Nagano, 2001, A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan), Cancer Causes Control, 112, 501, 10.1023/A:1011297326696

Bushman, 1998, Green tea and cancer in humans: a review in literature, Nutr Cancer, 31, 151, 10.1080/01635589809514697

Yang, 2000, Tea and tea polyphenols in cancer prevention, J Nutr, 130, 472S, 10.1093/jn/130.2.472S

Yang, 2000, Recent advances in nutritional sciences, J Nutr, 130, 2409, 10.1093/jn/130.10.2409

Hecht, 1999, Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism, J Nutr, 129, 768S, 10.1093/jn/129.3.768S

Zhang, 1994, Anticarcinogenic activities of organic isothiocyanates, Cancer Res, 54, 1976S

Getahun, 1999, Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress, Cancer Epidemiol Biomarkers Prev, 8, 447

Hecht, 2000, Inhibition of carcinogenesis by isothiocyanates, Drug Metab Rev, 32, 395, 10.1081/DMR-100102342

Crowell, 1999, Prevention and therapy of cancer by dietary monoterpenes, J Nutr, 129, 775S, 10.1093/jn/129.3.775S

Gould, 1995, Prevention and therapy of mammary cancer by monoterpenes, J Cell Biochem Suppl, 22, 139, 10.1002/jcb.240590818

Elson, 1995, Coupling the cholesterol- and tumor-suppressive actions of palm oil to the impact of its minor constituents on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, Prostaglandins Leukot Essent Fatty Acids, 52, 205, 10.1016/0952-3278(95)90024-1

Gould, 1994, Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras, Cancer Res, 54, 3540

Low-Baselli, 2000, Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis, Carcinogenesis, 21, 1869, 10.1093/carcin/21.10.1869